CN101302251A - 霞水母来源有免疫增强活性的糖蛋白及其制备和应用 - Google Patents
霞水母来源有免疫增强活性的糖蛋白及其制备和应用 Download PDFInfo
- Publication number
- CN101302251A CN101302251A CNA2008100249131A CN200810024913A CN101302251A CN 101302251 A CN101302251 A CN 101302251A CN A2008100249131 A CNA2008100249131 A CN A2008100249131A CN 200810024913 A CN200810024913 A CN 200810024913A CN 101302251 A CN101302251 A CN 101302251A
- Authority
- CN
- China
- Prior art keywords
- glycoprotein
- preparation technology
- jellyfish
- cyanea
- rosy clouds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000694 effects Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims description 23
- 230000002434 immunopotentiative effect Effects 0.000 title description 2
- 102000003886 Glycoproteins Human genes 0.000 claims abstract description 44
- 108090000288 Glycoproteins Proteins 0.000 claims abstract description 44
- 241000242583 Scyphozoa Species 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 10
- 241000948383 Cyanea nozakii Species 0.000 claims abstract description 5
- 229940037003 alum Drugs 0.000 claims abstract description 5
- 150000001413 amino acids Chemical class 0.000 claims abstract description 5
- 239000003814 drug Substances 0.000 claims abstract description 5
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 5
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 5
- 241001126326 Cyanea <Cnidaria> Species 0.000 claims abstract description 4
- 241001126325 Cyanea capillata Species 0.000 claims abstract description 3
- 241000825992 Cyanea purpurea Species 0.000 claims abstract description 3
- 239000004475 Arginine Substances 0.000 claims abstract 2
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims abstract 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000004473 Threonine Substances 0.000 claims abstract 2
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims abstract 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims abstract 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 26
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 238000005516 engineering process Methods 0.000 claims description 19
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 16
- VEXZGXHMUGYJMC-UHFFFAOYSA-N hydrochloric acid Substances Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 12
- 238000012545 processing Methods 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 238000000108 ultra-filtration Methods 0.000 claims description 9
- 238000010612 desalination reaction Methods 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 8
- 238000002791 soaking Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 6
- 238000005119 centrifugation Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- OAABHEHWRQAHEJ-UHFFFAOYSA-N butan-1-ol;chloroform Chemical compound ClC(Cl)Cl.CCCCO OAABHEHWRQAHEJ-UHFFFAOYSA-N 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 102000029816 Collagenase Human genes 0.000 claims description 4
- 108060005980 Collagenase Proteins 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 claims description 4
- 229960002424 collagenase Drugs 0.000 claims description 4
- 229940088598 enzyme Drugs 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 108090000145 Bacillolysin Proteins 0.000 claims description 3
- 102000035092 Neutral proteases Human genes 0.000 claims description 3
- 108091005507 Neutral proteases Proteins 0.000 claims description 3
- -1 Sumizyme MP Proteins 0.000 claims description 3
- 238000011033 desalting Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 235000013305 food Nutrition 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 2
- 102000035101 Aspartic proteases Human genes 0.000 claims description 2
- 108091005502 Aspartic proteases Proteins 0.000 claims description 2
- 108090000317 Chymotrypsin Proteins 0.000 claims description 2
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 229960002376 chymotrypsin Drugs 0.000 claims description 2
- 235000019253 formic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 229910017604 nitric acid Inorganic materials 0.000 claims description 2
- 231100000252 nontoxic Toxicity 0.000 claims description 2
- 230000003000 nontoxic effect Effects 0.000 claims description 2
- 210000000496 pancreas Anatomy 0.000 claims description 2
- 235000021110 pickles Nutrition 0.000 claims description 2
- 238000003825 pressing Methods 0.000 claims description 2
- 210000002784 stomach Anatomy 0.000 claims description 2
- 241000251468 Actinopterygii Species 0.000 claims 1
- 241001062472 Stokellia anisodon Species 0.000 claims 1
- 230000002708 enhancing effect Effects 0.000 claims 1
- 238000007667 floating Methods 0.000 claims 1
- 230000020978 protein processing Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 abstract description 2
- 230000002766 immunoenhancing effect Effects 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 150000002772 monosaccharides Chemical class 0.000 abstract 1
- 230000009965 odorless effect Effects 0.000 abstract 1
- 238000009938 salting Methods 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 10
- 230000036737 immune function Effects 0.000 description 10
- 230000000242 pagocytic effect Effects 0.000 description 7
- 239000003228 hemolysin Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 108010006464 Hemolysin Proteins Proteins 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 206010053613 Type IV hypersensitivity reaction Diseases 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000005951 type IV hypersensitivity Effects 0.000 description 4
- 208000027930 type IV hypersensitivity disease Diseases 0.000 description 4
- 241000243321 Cnidaria Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000001539 phagocyte Anatomy 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010021703 Indifference Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 235000021438 curry Nutrition 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000370738 Chlorion Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000251511 Holothuroidea Species 0.000 description 1
- 238000011887 Necropsy Methods 0.000 description 1
- 241000195474 Sargassum Species 0.000 description 1
- 241000242589 Semaeostomeae Species 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000005965 immune activity Effects 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 231100000567 intoxicating Toxicity 0.000 description 1
- 230000002673 intoxicating effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
Images
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (16)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100249131A CN101302251B (zh) | 2008-05-20 | 2008-05-20 | 霞水母来源有免疫增强活性的糖蛋白及其制备和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008100249131A CN101302251B (zh) | 2008-05-20 | 2008-05-20 | 霞水母来源有免疫增强活性的糖蛋白及其制备和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101302251A true CN101302251A (zh) | 2008-11-12 |
CN101302251B CN101302251B (zh) | 2011-04-20 |
Family
ID=40112365
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008100249131A Expired - Fee Related CN101302251B (zh) | 2008-05-20 | 2008-05-20 | 霞水母来源有免疫增强活性的糖蛋白及其制备和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101302251B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819552A (zh) * | 2014-02-17 | 2014-05-28 | 中国人民解放军第二军医大学 | 一种发形霞水母多肽生长因子及其制备方法和应用 |
CN113318003A (zh) * | 2021-04-08 | 2021-08-31 | 海臻(上海)生物科技有限公司 | 一种水母多肽及其应用 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101609217B1 (ko) * | 2015-07-30 | 2016-04-05 | (주)더마랩 | 해파리로부터 당단백질을 제조하는 방법 및 그 당단백질을 함유하는 화장료 조성물 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101156644A (zh) * | 2007-05-24 | 2008-04-09 | 张丽丽 | 一种以霞水母为原料制备高纯度高粘度胶原蛋白的工艺 |
CN101156643A (zh) * | 2007-05-24 | 2008-04-09 | 张丽丽 | 一种以霞水母为原料制备水解胶原蛋白的工艺 |
-
2008
- 2008-05-20 CN CN2008100249131A patent/CN101302251B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103819552A (zh) * | 2014-02-17 | 2014-05-28 | 中国人民解放军第二军医大学 | 一种发形霞水母多肽生长因子及其制备方法和应用 |
CN103819552B (zh) * | 2014-02-17 | 2016-01-13 | 中国人民解放军第二军医大学 | 一种发形霞水母多肽生长因子及其制备方法和应用 |
CN113318003A (zh) * | 2021-04-08 | 2021-08-31 | 海臻(上海)生物科技有限公司 | 一种水母多肽及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN101302251B (zh) | 2011-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101353380A (zh) | 霞水母来源有免疫增强活性的胶原蛋白肽及制备和应用 | |
CN101972004B (zh) | 牡蛎酶解物的制备方法及应用 | |
CN103255186A (zh) | 鲍鱼多糖、脂质和蛋白肽的联产制备方法 | |
CN101284872B (zh) | 一种抗氧化活性肽及其制备方法 | |
CN109207544A (zh) | 一种小球藻抗氧化多肽的制备方法 | |
CN110272485B (zh) | 超声酸预处理辅助酸酶法提取白鲢鱼鱼皮胶原蛋白的方法 | |
CN109504732A (zh) | 一种牡蛎活性肽的制备方法 | |
CN105255974A (zh) | 一种利用枯草芽孢杆菌发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN101302251B (zh) | 霞水母来源有免疫增强活性的糖蛋白及其制备和应用 | |
CN101544965B (zh) | 从猪胎盘中提取多种生物活性物质的联产工艺 | |
CN109221892A (zh) | 果胶低聚糖及其制备方法和作为AGEs抑制剂的应用 | |
CN101585873A (zh) | 从海参加工废弃液中回收蛋白质及粗多糖的方法 | |
CN105255972A (zh) | 一种利用米曲霉发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN101234126A (zh) | 霞水母来源具有抗疲劳活性的胶原蛋白肽及其制备工艺 | |
CN103951737A (zh) | 一种从海藻中提取亲糖蛋白的方法 | |
CN101230375B (zh) | 一种霞水母来源的具有抗疲劳活性的糖蛋白及其制备工艺 | |
CN105255982A (zh) | 一种利用米曲霉发酵罗非鱼鱼皮制备抗氧化活性肽的方法 | |
CN101445819A (zh) | 从盐藻渣中制备水解低聚糖和短肽的方法 | |
CN102273633A (zh) | 一种牡蛎肽口服液的制造方法 | |
CN110627863B (zh) | 蛋白多糖提取方法、提取物及其应用和化妆品 | |
CN104945503A (zh) | 一种利用猪血制备亚硝基血红蛋白的方法 | |
CN103555527B (zh) | 蛇肽保健酒及其制备方法 | |
CN108047344B (zh) | 大豆螺旋藻复合提取物的制备方法及其在水松纸上的应用 | |
CN105996021A (zh) | 一种富含氨基酸的抗衰老海洋蛋白保健品及其制备方法 | |
CN106636267A (zh) | 一种小分子参蚝多肽的提取方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C57 | Notification of unclear or unknown address | ||
DD01 | Delivery of document by public notice |
Addressee: Zhang Lili Document name: Notice of application for publication of patent for invention and entry into the substantive examination procedure |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Jiangsu Litian Technologies Co., Ltd. Assignor: Zhang Lili|Jiangnan University Contract record no.: 2011320000338 Denomination of invention: Cyanea-originated glucoprotein having immunopotentiation activity, preparation and use thereof License type: Exclusive License Open date: 20081112 Record date: 20110321 |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: JIANGNAN UNIVERSITY Effective date: 20121121 Owner name: JIANGSU LITIAN TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: ZHANG LILI Effective date: 20121121 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200127 PUDONG NEW AREA, SHANGHAI TO: 226408 NANTONG, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20121121 Address after: 226408 Jiangsu city of Nantong province Rudong county new Feng Li Zhen Road No. 120 Patentee after: Jiangsu Litian Technology Co., Ltd. Address before: 200127, room 16, No. 1650, Lane 1601, Jinxiu Road, Shanghai, Pudong New Area Patentee before: Zhang Lili Patentee before: Jiangnan University |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110420 Termination date: 20190520 |